STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$4.59
+0.12 (+2.68%)
Open$4.46
Previous Close$4.47
Day High$4.67
Day Low$4.43
52W High$8.33
52W Low$1.72
Volume—
Avg Volume1.02M
Market Cap473.57M
P/E Ratio—
EPS$-0.51
SectorBiotechnology
Analyst Ratings
Strong Buy
17 analysts
Price Target
+970.6% upside
Current
$4.59
$4.59
Target
$49.14
$49.14
$35.75
$49.14 avg
$66.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.47M | 1.27M | 31.76M |
| Net Income | -71,432,366 | -55,690,514 | 1.18M |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% |
| EBITDA | -69,986,202 | -57,594,327 | 2.48M |
| Free Cash Flow | — | — | 903.7K |
| Rev Growth | +15.4% | +15.4% | -3.0% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $283.54 | -0.86% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $438.82 | -1.14% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $166.53 | -1.45% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $520.66 | -2.94% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $923.34 | -2.35% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $147.82 | -1.06% | 7.7 | 20.98B |